Literature DB >> 9632064

Comparison of the original and the modified Larsen methods and the Sharp method in scoring radiographic progression in early rheumatoid arthritis.

L Paimela1, L Laasonen, T Helve, M Leirisalo-Repo.   

Abstract

OBJECTIVE: To compare the original Larsen method and the proposed modification of the Larsen method with omission of scoring soft tissue swelling and periarticular osteoporosis, and the Sharp method in measurement of radiographic progression in early rheumatoid arthritis (RA).
METHODS: Radiographs of hands and feet were assessed by the 3 scoring methods at Months 0 and 12 in 83 patients with recent onset RA. Sensitivity to change was determined using standardized response mean (SRM).
RESULTS: Highly significant radiographic progression was observed by all 3 methods. The modified Larsen method showed the largest SRM (0.88), but the differences were slight between the 3 scoring methods (SRM 0.80 for the original Larsen method, SRM 0.72 for the Sharp method). High interobserver reproducibility was observed for all methods tested.
CONCLUSION: In early RA the sensitivity to change of all 3 scoring methods was high, but in this patient population the newly modified Larsen method was the most responsive method.

Entities:  

Mesh:

Year:  1998        PMID: 9632064

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  2 in total

Review 1.  Radiographic scoring methods as outcome measures in rheumatoid arthritis: properties and advantages.

Authors:  S Boini; F Guillemin
Journal:  Ann Rheum Dis       Date:  2001-09       Impact factor: 19.103

2.  Cyclosporin A monotherapy versus cyclosporin A and methotrexate combination therapy in patients with early rheumatoid arthritis: a double blind randomised placebo controlled trial.

Authors:  A H Gerards; R B M Landewé; A P A Prins; G A W Bruyn; H S Goei Thé; R F J M Laan; B A C Dijkmans; G A W Bruijn
Journal:  Ann Rheum Dis       Date:  2003-04       Impact factor: 19.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.